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Abstract
Background: In recent years there has been increasing recognition that the pattern of presentation of
coeliac disease may be changing. The classic sprue syndrome with diarrhoea and weight loss may be less
common than the more subtle presentations of coeliac disease such as an isolated iron deficiency anaemia.
As a result, the diagnosis of this treatable condition is often delayed or missed. Recent serologic screening
tests allow non-invasive screening to identify most patients with the disease and can be applied in patients
with even subtle symptoms indicative of coeliac disease. Both benign and malignant complications of
coeliac disease can be avoided by early diagnosis and a strict compliance with a gluten free diet.
Aim: The aim of this study is to evaluate the trends in clinical presentation of patients diagnosed with adult
coeliac disease. In addition, we studied the biochemical and serological features and the prevalence of
associated conditions in patients with adult coeliac disease.
Methods: This is an observational, retrospective, cross-sectional review of the medical notes of 32 adult
patients attending the specialist coeliac clinic in a district general hospital.
Results: Anaemia was the most common mode of presentation accounting for 66% of patients. Less than
half of the patients had any of the classical symptoms of coeliac disease and 25% had none of the classical
symptoms at presentation. Anti-gliadin antibodies, anti-endomysial antibody and anti-tissue
transglutaminase showed 75%, 68% and 90% sensitivity respectively. In combination, serology results were
100% sensitive as screening tests for adult coeliac disease. Fifty nine percent patients had either
osteoporosis or osteopenia. There were no malignant complications observed during the follow up of our
patients.
Conclusion: Most adults with coeliac disease have a sub clinical form of the disease and iron deficiency
anaemia may be its sole presenting symptom. Only a minority of adult coeliac disease patients present with
classical mal-absorption symptoms of diarrhoea and weight loss. Patients with atypical form of disease
often present initially to hospital specialists other than a gastro-enterologist. An awareness of the broad
spectrum of presentations of adult coeliac disease, among doctors both in primary care and by the various
hospital specialists in secondary care, is necessary to avoid delays in diagnosis. It is important to include
serological screening tests for coeliac disease systematically in the evaluation of adult patients with
unexplained iron deficiency anaemia or unexplained gastro-intestinal symptoms and in those who are
considered to be at increased risk for coeliac disease.
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Background
Coeliac disease is an immunologically mediated enterop-
athy caused by a permanent intolerance to ingested gluten
in genetically susceptible individuals [1-3]. Its prevalence
rates in Caucasians in Europe, North and South America,
Australia and the Middle East have been reported to be as
high as 1 in 100 [4-6]. Typically, coeliac disease presents
with symptoms of mal-absorption such as weight loss,
diarrhoea, steatorrhoea, or abdominal distension. How-
ever, the symptoms of coeliac disease are diverse and it
may present with a broad spectrum of clinical features
such as isolated sub-clinical iron deficiency anaemia, oste-
oporosis, neurologic disease, non-specific abdominal
symptoms, dermatitis herpetiformis or malignancies.
In recent years there has been increasing recognition that
the mode of presentation of coeliac disease may be chang-
ing [7,8]. It often presents with symptoms not previously
considered to be characteristic of the disease [3,9,10].
While most gastroenterologists appreciate the broader
spectrum of the disease, and its increasing prevalence, it is
still perceived by most general practitioners as a rare con-
dition of childhood or infancy, presenting mainly with
gastrointestinal symptoms suggestive of malabsorption
[9]. There is concern that many patients with this disease
are being overlooked due to failure of clinicians to con-
sider it in the initial differential diagnosis when they
present with non-classical symptoms [8]. These so-called
"silent" coeliac disease patients lack diarrhoea and these
non-diarrhoeal presentations now are seen more com-
monly than those with diarrhoea.
Early diagnosis of coeliac disease is important. In many
patients with coeliac disease, the diagnosis is considered
only when they present with avoidable complications
such as a malignancy [11,12]. There is evidence that com-
pliance with gluten free diet is protective against compli-
cations of coeliac disease, such as disorders of bone
metabolism [13-15] and particularly non-Hodgkin's lym-
phoma [16], the most commonly associated malignant
complication of coeliac disease [11].
Methods
This is a retrospective study of patients attending specialist
adult coeliac disease clinic in a district general hospital in
rural South Wales. Case records of all patients with adult
coeliac disease who attended three consecutive clinics
were reviewed. This clinic was a specialist multidiscipli-
nary adult celiac disease clinic run by a specialist physi-
cian and a specialist dietitian in a district general hospital
in rural South Wales. The diagnosis of coeliac disease was
based on compatible serologic tests, small bowel biopsy,
and response to a gluten free diet. Adult coeliac disease
was diagnosed if the clinical presentation was after 16
years of age. The case notes were reviewed regarding the
following:
1. The clinical presentation including age at diagnosis, sex
distribution, source and reason for referral; presenting
symptoms, the time delay between onset of symptoms
and the diagnosis, family history of coeliac disease or
autoimmune disorders and the presence of any associated
disorders including dermatitis herpetiformis.
2. The laboratory parameters at diagnosis including hae-
matologic tests – full blood count, red cell folate, ferritin,
serum B12; serological screen (Elisa technique) anti-glia-
din antibodies (IgA), endomysial antibodies (IgA), anti-
transglutaminase antibodies (IgA);
3. Small bowel biopsy result at diagnosis (Marsh classifi-
cation);
4. Results of bone density scans – (dual energy x-ray
absorptiometry: DEXA scan) – first scan following diagno-
sis.
If the relevant serological screening tests were not per-
formed at the time of diagnosis, these cases were excluded
from this study. Twelve (38%) anti-gliadin antibody val-
ues, 10 (31%) anti-endomysial antibody reports, and 4
(13%) anti-tTG results were not available; these patients
were also excluded from the study. Four (13%) ferritin, 5
(16%) folate and 6 (19%) B12 test results were not
obtainable, and these were excluded as well. In patients
who were already on treatment for anaemia prior to the
diagnosis of coeliac disease, haematological values before
commencement of iron, B12 or folate replacement ther-
apy were taken for analysis – as medication would have
restored the subsequent values, thus creating a falsely low
rate of anaemia at diagnosis, in these patients.
Results
Case records of 32 consecutive adult coeliac disease
patients attending three consecutive clinics fulfilled our
criteria for inclusion in this study. The mean age at diag-
nosis was 53.2 years with a range of 23–86 years. There
were two peaks in age at diagnosis, one in the 4th and the
second, in the 6th decade (Figure 1). The ratio of male:
female cases was 2:3. The duration of symptoms before
diagnosis ranged from 1 week to 25 years, with a mean
delay in diagnosis by 71 months. There was no correlation
between age at diagnosis and time elapsed between onset
of symptoms and diagnosis in this study (r = 0.18, p >
0.05), thus the possibility of age related diagnostic delay
is effectively ruled out.Nutrition Journal 2006, 5:24 http://www.nutritionj.com/content/5/1/24
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Referral source
Thirty eight percent of patients were referred from primary
care by the general practitioners; most of the remaining
patients were referred from secondary care: 9% were diag-
nosed during inpatient evaluation following an emer-
gency admission to hospital with acute episodes of
abdominal pain, diarrhoea or vomiting. The remaining
patients were referred by hospital specialists other than
gastroenterologists: 22% by a haematologist, 9% by a sur-
geon, 22% by general hospital physicians and care of the
elderly specialists (chronic anaemia), or a gynaecologist
(abdominal pain), dermatologist (skin rash) and rheuma-
tologist (iron-deficiency anaemia) (figure 2).
Presenting complaints
Anaemia was the most common mode of presentation:
68% patients had low iron stores (ferritin <20 ng/l) at
diagnosis, 50% had a reduced haemoglobin, 35% had a
low mean corpuscular volume (MCV) and 45% a low red
blood cell count. 13% patients of our patients had anae-
mia with a high MCV at diagnosis; moreover, in some
patients, a normal MCV might reflect a mixed nutritional
anaemia since 57% our patients had either low folate or
low B12 levels.
Less than 50% patients had at least one of the "classical"
symptoms of coeliac disease; 25% (8 patients) had none
of the "classical" symptoms at presentation and all these
8 subjects were found to have iron-deficiency anaemia.
Only one patient (3%) had dermatitis herpetiformis
although 25% cases suffered with skin conditions "diag-
nosed" as follicular rash, eczema, seborrheic dermatitis,
lichen planus or pruritus of unknown aetiology.
Co morbidities
Thyroid disorders were the most common disease associ-
ated with coeliac disease in this study. Amongst patients
with thyroid disease, 57% had hypothyroidism and 29%
were thyrotoxic while the remaining patient had thyroidi-
tis. Eighty three percent of the cases with affective disorder
had depression. Fifty seven percent of patients with asso-
ciated arthritis had an inflammatory type of arthritis.
Fourteen percent of patients were noted to have selective
IgA deficiency. The prevalence of pernicious anaemia was
9%, primary biliary cirrhosis 6%, and one patient had
inflammatory bowel disease. Atopic disease was present
in 6% of cases and one patient had sarcoidosis. No
patients in this study had either type 1 diabetes mellitus or
Sjögren's syndrome.
Family history
Three patients had a positive family history with a diagno-
sis of coeliac disease in a first degree relative. In addition,
16% of our patients gave a history of other autoimmune
diseases in the family.
Serological screening tests
Seventy five percent of patients were found to have posi-
tive anti-gliadin antibodies (AGA) at diagnosis and 68%
had positive endomysial antibodies (EMA) while 91%
patients were positive for EMA, AGA or both (95% confi-
dence interval 79.3–102.7%). 90% had positive anti-tTG
(95% CI 71.4–108.5%). However, only eight patients had
had all 3 antibody screening tests performed at the time of
initial diagnosis, since these tests had not been widely
available until much later.
Histology
The most common finding (47%) was partial villous atro-
phy; 22% had subtotal villous atrophy and 16% partial-
subtotal villous atrophy, while only 13% patients demon-
strated total villous atrophy (figure 3). A statistically sig-
nificant correlation was found between the degree of
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villous atrophy (no evidence of atrophy = 0, partial v.a. =
1, partial-subtotal v.a. = 2, subtotal v.a. = 3, total v.a. = 4)
and AGA levels at diagnosis (r = 0.481, p = 0.013) (figure
4). The biopsy in one patient (3%) showed only an
increase in the intraepithelial lymphocytes.
Complications
Osteoporosis was the most common and also the only
complication related to coeliac disease found among our
32 patients. Osteoporosis was present in 28%, with
another 31% of patients were classified as osteopenic
(osteoporosis = T score < -2.5, osteopenia = T score < -1.0).
DEXA scans were carried out a mean of 124.7 months
after onset of symptoms (and mean 43.4 months follow-
ing diagnosis). There was no correlation between T score
and the duration of symptoms before the DEXA scan (L-
spine: r = -0.64, p = 0.757; hip: r = -0.108, p = 0.601), or
between T score and the length of time elapsed following
diagnosis before the DEXA scan (L-spine r = -0.320, p =
0.110; hip r = -0.0.279, p = 0.167).
There were a total four patients in our group, in whom a
diagnosis of malignancy had been made on follow up: 2
with basal cell carcinoma, 1 each with breast cancer and
melanoma. There were no cases of lymphoma, adenocar-
cinoma of the small intestine or oesophageal or pharyn-
geal carcinoma i.e. neoplasms thought to arise as a
complication of coeliac disease.
Discussion
Adult coeliac disease may present with classic clinical fea-
tures including weight loss, diarrhoea, and malabsorption
of nutrients. However, there are reports of an increasing
trend towards silent or subclinical presentations i.e. pres-
entation with subtle symptoms not clearly related to gas-
trointestinal system. Nonspecific symptoms and
nutritional deficiencies are especially common in older
patients and as a result, the diagnosis of this treatable con-
dition is often delayed or missed. Without active serologic
screening, most cases of coeliac disease probably remain
undiagnosed. The mean age at diagnosis in this study was
53.2 years with peaks in the 4th and 6th decades. Similar
age distribution has been reported in other studies [8,10].
Coeliac disease is more common in women than men
[17,18] and the cases presented in this study concur with
this, with a male: female ratio of 2:3. It is known that
women actively seek health advice more readily than men
[7,19], and the high relative incidence in women may
thus be a result of this behavioural pattern. It is also pos-
sible that the higher incidence in women could be due to
the increased nutritional demands of women during the
reproductive years [7]. This is supported by the finding
that in children the ratio of boys: girls with coeliac disease
approaches 1: 1 [7,20].
Only thirty eight percent of cases in this study were
referred directly from primary care by their general practi-
tioners. Twenty two percent of patients were referred
directly by a haematologist, reflecting the high incidence
of anaemia among the group.
Delays in diagnosis of coeliac disease and initiation of a
gluten-free diet may predispose patients to developing
complications [13-15]. It has been shown that adherence
to a strict gluten-free diet is protective against malignancy
in coeliac disease [16]. A cohort study of 210 patients with
coeliac disease who followed a gluten-free diet for a mean
of 18.5 years, found that the risk of developing cancer is
not significantly increased in those who followed a gluten
free diet for five years or more when compared with the
normal population [16]. This study found however, that
those taking a reduced gluten or normal diet had an
increased risk of developing cancer, especially lympho-
mas and cancers of the mouth, pharynx and oesophagus.
Disorders of calcium and bone metabolism were the most
prevalent complications seen in coeliac disease in our
study. Thirty one percent were osteopenic while 28% had
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osteoporosis and one patient had secondary hyperparath-
yroidism. In patients with coeliac disease, delay in diagno-
sis and hence delayed treatment leads to an increased risk
of development of osteopenia or osteoporosis [13]. In
addition, there is evidence to show that compliance with
a gluten-free diet increases the bone mineral density of
osteopenic coeliac patients [14,15].
The most common presenting complaint in this study was
iron-deficiency anaemia. Non-specific abdominal pain or
discomfort, often longstanding was also a common pre-
senting symptom. Some of our patients, who had non-
specific abdominal pain as the primary symptom, had
undergone prolonged investigations elsewhere, before the
diagnosis of coeliac disease was considered. Six of these
13 patients with non-specific abdominal pain had had a
chronic undiagnosed anaemia for years before developing
gastrointestinal symptoms which eventually led to their
diagnosis.
Zipser et al. [10], in their study conducted in the USA
reported fatigue to be one of the most common present-
ing symptom, with 82% patients complaining of this.
However, fatigue was not seen as a significant symptom in
our study and it was reported in only 31% of case notes. A
comparison between the findings of this study and those
by Zipser et al. are shown in table 1.
Although 57% patients had either low folate or low B12
levels at the time of diagnosis, a raised MCV was seen only
in a minority of patients (13%). However, 91% of those
patients with a normal MCV despite low folate or B12 lev-
els also had low ferritin levels, reflecting their mixed defi-
ciency anaemia, thus explaining their normocytic blood
film.
Dermatitis herpetiformis was seen in only one patient in
this study. However, since the diagnosis of dermatitis her-
petiformis is made by skin biopsy showing pathogno-
monic granular IgA deposits in the papillary dermis in
apparently unaffected skin, with increased numbers of
activated T cells [21], an accurate diagnosis is unlikely to
be made unless it was specifically suspected by the physi-
cian. Thus the follicular rashes, seborrhoeic dermatitis,
lichen planus and pruritis recorded in the case-notes in
some of our patients may actually represent undiagnosed
cases of dermatitis herpetiformis.
Family history was considered as positive if any first
degree relative of our patients also had a diagnosis of coe-
liac disease and three cases met these criteria. In family
screening studies, around 10% of first degree relatives of
coeliac disease patients are diagnosed with coeliac dis-
ease[8]. However, since we did not perform routine sero-
logical screening tests on the first degree relatives, we
would have missed undiagnosed, sub-clinical or silent
celiac disease in the family.
Sixteen percent of our patients had a first degree relative
with an autoimmune disorder. The prevalence of autoim-
mune disorders among relatives of coeliac disease patients
has been shown to be higher than among the general pop-
ulation. It was also shown that those relatives with an
autoimmune disease were more likely to have silent,
rather than symptomatic, coeliac disease [22].
The most common associated disorder seen in our
patients presented here was thyroid disease (22% patients
affected). There is a well-recognised association between
these two diseases [3,11,23,24]. One explanation for the
association between coeliac disease and thyroid disorders
is the coexistence of HLA molecules in both diseases [23]
and HLA DR3 [23,24], HLA B8 [23] and HLA DQ8 [24]
have been implicated. An alternative hypothesis is that the
autoimmune reaction which occurs in the presence of glu-
ten in coeliac disease patients promotes the development
of autoimmune disorders [25]. Furthermore, it has been
shown that these auto-antibodies disappear on with-
drawal of gluten from the diet [26]. Many of the coeliac
disease associated disorders are autoimmune in nature
and 34% of patients in our study were found to have a
coexisting autoimmune disorder. These results are similar
to those reported by Collin et al. [27], where 28% coeliac
disease patients had an associated disorder considered to
be of autoimmune origin.
Arthritis and affective disorders were jointly the second
most common associated disorder found among patients
with coeliac disease in this study. Although, rheumatoid
arthritis is frequently quoted as being coeliac-associated
[17,28,29], there is little evidence in the literature to sup-
port this association [30,31]. However, there is some evi-
dence to support the concept of an associated
enteropathic arthritis in patients with coeliac disease as
has been suggested by Lubrano et al. [29]
Table 1: Comparison between the presenting complaints of 
patients in this study compared to those in the study of Zipser et 
al.10
Complaint Current study (%) Zipser et al (%)
Anaemia 66 63
Abdominal pain or discomfort 41 77
Diarrhoea 38 52
Fatigue 31 82
Nausea and/or vomiting 28 46
Weight loss 28 55
Depression 19 46
Generalised aches and pains 19 42Nutrition Journal 2006, 5:24 http://www.nutritionj.com/content/5/1/24
Page 6 of 8
(page number not for citation purposes)
Nineteen percent of patients in this study had been diag-
nosed with an affective disorder. Fera et al. [32] suggest
that affective disorders in coeliac disease are reactive,
resulting from the impact of initial diagnosis and subse-
quent adjustment to a gluten-free diet. They recommend
preventative supportive psychologic interventions in
patients with a new diagnosis of coeliac disease.
The association between coeliac disease and IgA defi-
ciency is widely recognised [27,33,34]. and this immuno-
logical disorder is common among coeliac disease
patients. The reason for this association is unclear and it is
not certain whether this is due to a common genetic factor
or whether one condition predisposes to the other. The
HLA alleles B8, DR3, DR7 and DQ2 are thought to be
likely candidates for a genetic cause as they are prevalent
in both conditions [27,33]. The primary concern regard-
ing this association is the potential for a false negative
serological tests for coeliac disease and hence missed diag-
nosis of coeliac disease as serological tests become the
principal form of screening. Thus Gillett et al. [34] have
argued that small bowel biopsy confirmation of diagnosis
becomes essential especially in patients with selective IgA
deficiency.
Although the associations between type 1 diabetes melli-
tus and Sjögren's syndrome with coeliac disease has been
well documented [3,8,11,20,23] neither of these disorders
were found among patients in this study. This is most
likely attributable to our small sample size.
Pernicious anaemia and primary biliary cirrhosis are
among the less frequently reported disorders associated
with coeliac disease; although, they were both relatively
prevalent among the patients studied here (9% and 6%
respectively). Three cases of pernicious anaemia were
found in our study; the association between pernicious
anaemia and coeliac disease has been somewhat underre-
ported in the literature [35].
Elevated transaminase levels is frequently found at diag-
nosis in patients of coeliac disease and liver cell damage,
characterised by inflammation and steatosis, has been
shown to resolve on a gluten-free diet [36,37]. The rela-
tionship between inflammatory bowel disease and coeliac
disease is well recognised [38]. Inflammatory bowel dis-
ease is more prevalent among first degree relatives of coe-
liac disease patients than the normal population [39].
However, only one of our 32 patients studied here had
proven ulcerative colitis, and Crohn's disease was not seen
in any.
There is a possible association between coeliac disease
and sarcoidosis [23,40]. One patient in this study had sar-
coidosis which, given the rarity of this disease in this age
group and in this population, may support the suggestion
of association between these two disorders.
Small intestinal biopsy was diagnostic in 97% patients
and was equivocal in only one patient who had an
increase in intraepithelial lymphocyte reported in his
duodenal biopsy. In this isolated case anti-tTG was signif-
icantly raised at 120.3 U/ml (reference range 0–10). This
patient had classical symptoms of abdominal discomfort
and diarrhoea noted to occur following ingestion of
wheat. He improved on a gluten free diet; his symptoms
disappeared; and his serology normalised. In patients
with positive small intestinal biopsies, it is to be noted
that most patients did not a have total villous atrophy: the
majority had only a partial villous atrophy. There was a
statistically significant association between the histologi-
cal grade and anti-gliadin antibody levels at diagnosis.
This would add support to the argument of some who
believe that serologic tests should now be the preferred
test, to be used in the initial screening of patients thought
to be at risk for coeliac disease [41].
Serological screening tests have improved case detection
of coeliac disease in patients with atypical presentation.
This study showed the sensitivity of EMA to be 68% and
that of AGA to be 75%. In combination these two anti-
bodies gave 91% sensitivity (95% CI 79.3–102.7%). The
sensitivity of tissue anti-tTG was 90% (95% CI 71.4–
108.5%). This demonstrates the tests to be 100% sensitive
in combination, even in this study with a small sample
size. Other studies have shown EMA to be 68–100% spe-
cific [42]; and when used in conjunction with AGA, a 98%
sensitivity has been reported [8]. Thus the results obtained
here do not differ significantly from those reported in pre-
vious studies [43].
Serological tests may be false-negative in cases of IgA defi-
ciency and hypogammaglobulinaemia [44]. Although
there were no IgA-deficient patients in the study, one
patient had hypogammaglobulinaemia. This patient how-
ever was not tested for anti-tTG at the time of diagnosis
but did have positive EMA and AGA.
With the introduction of serologic tests for coeliac disease,
disease variants have been recognised which present with
atypical features such as fatigue, asymptomatic iron defi-
ciency, decreased bone density and dyspepsia without the
classic malabsorption syndrome. Other presentations
could include isolated hypoalbuminaemia, elevated ami-
notransferase levels (transaminitis), microscopic colitis,
symptoms of irritable bowel syndrome, recurrent aph-
thous stomatitis, infertility, neurologic symptoms such as
peripheral neuropathy, ataxia and epilepsy with posterior
cerebral calcification. The findings of this study suggest
that patients presenting to their general practitioner withNutrition Journal 2006, 5:24 http://www.nutritionj.com/content/5/1/24
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unexplained iron deficiency anaemia, unexplained fatigue
or generalised abdominal pain should undergo serologi-
cal testing for coeliac disease.
Conclusion
Most adults with coeliac disease have a sub-clinical form
of the disease and iron deficiency anaemia may be its sole
presenting symptom. Only a minority of adult coeliac dis-
ease patients present with classical mal-absorption symp-
toms of diarrhoea and weight loss. Patients with atypical
form of disease often present initially to hospital special-
ists other than a gastro-enterologist. It is important to
include serological screening tests for coeliac disease sys-
tematically in the evaluation of adult patients with unex-
plained iron deficiency anaemia or unexplained gastro-
intestinal symptoms and in those who are considered to
be at increased risk for coeliac disease.
An awareness of the broad spectrum of presentation of
patients with coeliac disease among doctors both in pri-
mary care and by the various hospital specialists in sec-
ondary care is necessary to avoid delays in diagnosis of
patients with adult coeliac disease. Adherence to a strict
gluten free diet is known to markedly reduce the risk of
coeliac disease related complications.
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